SBIR/STTR Research Award
High intensity collapsible phototherapy device for neonatal jaundice for home use
Award amount
$999,924Program and phase
SBIR · Phase IIAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Little Sparrows Technologies LLC
- Proposal award date
- 2016-08-15
- Contract end date
- 2019-04-30
- UEI
- KNGHKFK4QA55
- Solicitation number
- PAR13-090
- Topic code
- NICHD
Research abstract
Approximately of all newborns worldwide risk permanent neurotoxic brain injury due severe neonatal
jaundice SNJ This condition generally occurring in the first two weeks of life is almost always cured with
high intensity blue light phototherapy In the United States most phototherapy is delivered in a neonatal
intensive care unit NICU because effective high intensity devices have engineering features limiting use to
that environment This current care practice has the undesirable consequence of separating mothers and
babies during a developmentally vulnerable time while breastfeeding is being established Approximately
otherwise well newborns require phototherapy each year The annual estimated health care costs for
treating SNJ in hospitals are in excess of $ million
Little Sparrows Technologies has developed the Bili Hut a novel portable high intensity radial
array phototherapy device for use at the motherandapos s bedside in the hospital or in the home Current
phototherapy devices sufficiently portable for home use do not deliver adequate phototherapy to meet the
American Academy of Pediatrics recommendations for high intensity phototherapy The Bili Hut meets
current phototherapy standards enables treatment in a motherandapos s post partum room during birth hospital
admission and eliminates the need for hospital readmissions for otherwise well jaundiced babies who can be
treated at home This will eliminate the stress of separation to the mother baby pair during treatment at a
substantially reduced cost
We have achieved our Phase I goal of creation of a next stage Bili Hut that demonstrates efficacy superior to
a market leading NICU phototherapy device through increased skin exposure to therapeutic light Our Phase II
aims will develop capabilities of thermostability and improved infant eye shielding from noxious blue light
exposure through an innovative comprehensive device design
Innovations in this project include the radial Bili Hut light array with reflective interior providing superior
light distribution the first environmental temperature modulated high intensity phototherapy device the first
high intensity phototherapy device to eliminate the need for infant eye protection and the first mother baby
friendly high intensity device that will enable use in the home Severe neonatal jaundice is one of the most common conditions resulting in
readmissions of newborns Current care practice requires treatment in a NICU to
ensure thermostability while providing high intensity therapy This causes stress
to families and healthcare costs of andgt $ K annually When fully realized the Bili
Hut will address this public health concern by delivery of portable high
intensity therapy with thermoregulation capability suitable for use at home
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.